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Studies adherent to international guidelines and epilepsy classification are needed to 
accurately record the incidence of isolated seizures, epilepsy and seizure-mimics 
within a population. Because the diagnosis of epilepsy is largely made through 
clinical assessment by experienced physicians, seizures and epilepsy are susceptible 
to misdiagnosis. Previous epidemiological studies in epilepsy have not captured 
‘seizure mimics’. We therefore sought to quantify the incidence of isolated seizures, 
epilepsy and seizure-mimics using the International League Against Epilepsy (ILAE) 
classification system. In this study multiple overlapping methods of case 
ascertainment were applied to a defined geographic region from 1st January 2017 to 
31st March 2017 to identify all patients presenting with first seizures (provoked and 
unprovoked), new diagnoses of epilepsy and seizure mimics. Over a three month 
period, from a population of 542,869 adults and children, 442 potential 
presentations were identified, and 283 met the inclusion criteria. Radiology 
databases were the source of the largest number of individual cases (n=153, 54%), 
while electroencephalogram (E.E.G.) databases were the source of the highest 
number of unique-to-source cases (those not identified elsewhere, n=60, 21%). No 
single case was picked up in every method of ascertainment. Among the 283 
included presentations, 38 (13%) were classed as first provoked seizures, 27 (10%) as 
first unprovoked seizures, 95 (34%) as new diagnosis of epilepsy and 113 (40%) as 
seizure mimics. Ten (3%) presentations were indeterminate. We present and apply a 
rigorous study protocol for investigation of the incidence of first seizures, new 
diagnosis of epilepsy and seizure mimics in a geographically defined region which is 
adherent to recently published international guidelines for epidemiological studies 
and epilepsy classification. We highlight the challenges in making a diagnosis of new-
onset epilepsy in patients presenting with a first seizure using the current ILAE 
definition of epilepsy, when epilepsy can be diagnosed in situations where the 






Epilepsy is a disorder of the brain characterized by an enduring predisposition to 
generate epileptic seizures and by the neurobiologic, cognitive, psychological, and 
social consequences of this condition [1]. Operationally, epilepsy can be diagnosed in 
3 circumstances: (i) at least 2 unprovoked (or reflex) seizures occurring more than 24 
hours apart, (ii) one unprovoked (or reflex) seizure and a probability of further 
seizures similar to the general recurrence risk (at least 60%) after 2 unprovoked 
seizures, occurring over the next 10 years, and (iii) diagnosis of an epilepsy syndrome 
[2]. The second situation is relatively common but difficult to apply in real life as 
judging that an individual patient has a 60% risk of further seizures is challenging.  
Epilepsy poses a substantial economic burden for health care systems, individuals 
and their families through direct costs of treatment and indirect costs such as loss of 
productivity and employment [3]. Epidemiological studies are necessary to define 
the full public health burden of epilepsy within a population, to provide information 
needed for early detection and treatment, and to set public health and health care 
priorities [4]. Assessment of patients presenting with first seizures is critical to 
differentiating epileptic seizures from other conditions that resemble epileptic 
seizures (‘seizure mimics’). Although first seizures and epilepsy are susceptible to 
misdiagnosis, to our knowledge there are no published epidemiological studies on 
seizure mimics  
 
There are significant disparities in reported prevalence and incidence of epilepsy 
worldwide. While some variation may be related to factors such as socioeconomic 
class, access to healthcare, stigmatization and exposure to environmental risk factors 
[5], a significant contributor to the variation in reported incidence and prevalence 
may be due to heterogeneous methodologies used across studies.  A recent meta-
analysis of 48 incidence studies noted significant heterogeneity between studies and 
estimated the pooled annual cumulative incidence of epilepsy as 67.77 per 100,000 
persons (95% confidence interval [CI] 56.6 to 81.0) with one outlier report of 189.96 
per 100,000 [6]. Methods of case ascertainment in published studies range from 
door-to-door population surveys, administrative database searches and surveys of 
neurology referral centers [7-9], thus providing variations in inclusion criteria and 
accuracy of case ascertainment. Many studies employ retrospective case 
ascertainment and lack of detailed diagnostic information often prohibits accurate 
classification of seizure and epilepsy type.   
 
In 2011, in an effort to promote consistency in definitions and methods used in 
epidemiological studies and to facilitate comparisons between populations, the 
International League Against Epilepsy (ILAE) proposed standards for epidemiologic 
studies and surveillance of epilepsy [4]. These guidelines emphasize the importance 
of using multiple overlapping methods of case ascertainment to maximize the 
sensitivity of case ascertainment. Furthermore, Standards of Reporting of 
Neurological Disorders (STROND) guidelines for reporting of incidence and 
prevalence studies in neuroepidemiology have been developed to facilitate better 
reporting of published data and allow comparisons between studies [10]. When 
applied to future studies, these guidelines will enhance population-based 
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epidemiological studies and encourage the collection of data useful for the 
promotion of public health. Finally, the ILAE has recently commissioned updated 
classifications systems for both seizures and epilepsy types [11,12]. These 
classification systems are user-friendly and allow classification of seizure and 
epilepsy type by taking into account results of E.E.G. and imaging investigations. To 
our knowledge, this is the first epidemiological study to incorporate these 
classifications.  
 
In Ireland, it has been estimated that 10 per 1,000 persons aged 18 years and older 
have a self-reported lifetime prevalence of epilepsy [13]. This study is the first to 
investigate the incidence of new onset seizures, epilepsy and seizure mimics in 
Ireland and, to our knowledge, the first to present epidemiological data on seizure 
mimics. We present our study protocol, adherent to ILAE and STROND guidelines, 
and findings for the first three months of data collection.  
 
3. Materials and Methods 
 
This study was carried out in the geographically defined area of Cork city and county 
over the course of the calendar year 2017, with an estimated total population of 
542,868 persons based on a census in 2016. Herein we present our study protocol 
and, to demonstrate its application, the results of case ascertainment for the first 
three months of data collection, 1st January 2017 to 31st March 2017.  
 
All acute medical hospitals were included with the exception of one solely private 
hospital that does not employ an on-site consultant neurologist. Acute seizures 
presenting to the medical assessment unit of that hospital are transferred to the 
tertiary university hospital in the city. The remaining 7 acute hospitals included in 
this study were as follows: 2 tertiary referral city center university hospitals, 2 
regional secondary level hospitals, 1 solely private city center hospital which accepts 
acute referrals and employs 2 consultant neurologists, 2 city center hospitals with 
facilities for rehabilitation of geriatric patients who have recently been acutely 
admitted elsewhere e.g. ortho-geriatrics rehabilitation.  This study also included 
community sources of case ascertainment as follows: all general practitioners (G.P.s) 
in Cork city and county who are registered with the Irish Medical Directory, all 
nursing homes and residential care centers registered with the Health Information 
and Quality Authority, and Epilepsy Ireland, the community based patient 
information and advocacy group.    
 
3.1 Inclusion and exclusion criteria 
 
We included all patients who had a suspected first seizure or new diagnosis of 
epilepsy from 1st January to 31st December 2017 whose registered address as per the 
hospital-based demographic information was within Cork city or county (defined 
area). The working diagnosis of ‘seizure’ had to be explicitly documented in medical 
correspondence during the patient’s assessment typically by a G.P. in the 
community, an emergency department triage nurse or physician, or senior hospital-
based physician. Any patient, normally resident in the defined area, who had a 
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suspected seizure during 2017 but presented to a hospital outside the area was 
included. These patients were identified through survey of G.P.s and neurologists in 
Cork city and county, where their ongoing care and follow up was based. All patients 
with an address outside of the defined area were excluded.  
 
We gathered information on all patients whose first presentation to medical services 
with a query of seizure occurred during 2017. In some cases, the date of the first 
clinical event was prior to the 2017 calendar year, but medical attention was first 
sought in 2017, for example, when a patient has a history of recurrent stereotyped 
events, but the possibility of these events being seizures had not yet been explicitly 
stated, or medical attention was not sought. Similarly, we continued to monitor a 
number of case ascertainment sources [Rapid Access Seizure Clinic (R.A.S.C.) 
referrals, electroencephalogram (E.E.G.) and radiology databases] up to 31st March 
2018 in order to complete the classification of patients who first presented in late 
2017.  By restricting our count to first presentation during 2017, we will avoid over- 
or under-ascertainment in the 2017 calendar year, and the number of first 
presentations classified will estimate the true incidence of each clinical subcategory. 
 
As per the ILAE epidemiologic guidelines [4], febrile seizures in children (3 months to 
6 years old) and neonatal seizures (<28 days old) were excluded from this study as 
they are felt to be separate from epilepsy per se. With regard to acute provoked 
seizures, we noted the incidence of their occurrence as a specific research question, 
but they were separated from epilepsy in the final analysis.  
 
3.2 ILAE Definitions 
 
i) An epileptic seizure is a transient occurrence of signs and/or symptoms due to 
abnormal excessive or synchronous neuronal activity in the brain [1]. 
ii) Epilepsy is a disease of the brain defined by any of the following conditions: i) at 
least two unprovoked (or reflex) seizures occurring >24 hours apart ii) one 
unprovoked (or reflex) seizure and a probability of further seizures similar to the 
general recurrence risk (at least 60%) after two unprovoked seizures, occurring over 
the next 10 years, or iii) diagnosis of an epilepsy syndrome [2].  
iii) Acute provoked seizures are epileptic seizures which occur in close temporal 
association with an acute systemic, metabolic or toxic insult or in association with an 
acute central nervous system insult [4]. The interval between the insult and the 
seizure may vary according to the underlying clinical condition (see Table 1). With 
regard to alcohol withdrawal seizures, the seizure must have occurred within 7-48 
hours of the last drink to be classified as an alcohol withdrawal seizure [14]. 
Alternatively, any patient with a history of alcohol abuse and acute provoked 
seizures from alcohol, who developed their first seizure independent from alcohol 
within the study period [and was therefore commenced on anti-epileptic drug 
(A.E.D)] was counted as a ‘new diagnosis of epilepsy’. Seizures in the setting of acute 
alcohol intoxication due to extremely high quantities consumed and seizures in 
association with withdrawal of benzodiazepines were classified as acute provoked 
seizures [14].  
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iv) For all patients with a new diagnosis of epilepsy, the 2017 ILAE position papers on 
classification of seizures and epilepsy were applied. Seizures were therefore 
classified as focal onset, generalised onset or unknown onset and further descriptors 
were applied where possible [11]. Epilepsy was classified as focal, generalised, focal 
and generalised or unknown depending on available data [12].  
 
 
3.3 Case ascertainment 
 
We broadly divided our case ascertainment methods into ‘hot pursuits’, where 
information was gathered prospectively on a daily basis from active inpatient 
databases and services, and ‘cold pursuits’ where data were periodically reviewed 
retrospectively and cases were cross-referenced to the study database to prevent 
duplication. For an overview of the process of case ascertainment and case analysis, 
please see Figure 2.  
 
3.3.1 ‘Hot pursuits’ 
 
i) Emergency departments. Triage recording systems vary in each of the hospitals 
and therefore it was necessary to screen emergency departments in different ways 
depending on the resources available. In the main university hospital of the city, 
electronic triage records allowed us to screen all patients presenting acutely to the 
emergency department and to identify all possible seizures. The electronic triage 
system was checked on a daily basis. Search terms including ‘seizure’, ‘epilepsy’, 
‘collapse’, ‘seizure-like events’ and ‘fits’ were screened for among the initial post-
triage electronic entries. The remaining hospitals operate paper based triage systems 
and a point of contact in each hospital was established to collect Medical Record 
Number (MRNs) by hand of all patients presenting with a possible seizure.  
ii) Radiology. The clinical indication for all CT and MRI brains performed in each of 
the included hospitals was reviewed systematically to capture all brain imaging 
requested for an indication of possible seizure. We included direct queries of ‘first 
seizure’ as well as more indirect queries such as ‘collapse with jerking’.  
iv) Inpatient services. Inpatient services with a high likelihood of assessing patients 
with first seizures were identified. These included neurology, geriatrics, oncology 
and neurosurgery inpatient services. These services were specifically targeted as it 
was felt that they might assess and treat patients for a possible seizure without 
necessarily ordering specific neurophysiology or neuroimaging investigations. These 
teams were contacted on a fortnightly basis in order to prompt recall of recent 
cases.  
v) Clinical Nurse Specialists (CNSs). CNSs from services felt to have a high likelihood 
of encountering patients with a first seizure were contacted on a monthly basis and 
asked to inform the study team of any new case. CNS in paediatrics, neurology and 
oncology participated in this study.  
 
3.3.2 ‘Cold pursuits’ 
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i) E.E.G. databases. There are three neurophysiology departments in the capture 
region, two public and one private. All paediatric and adult E.E.G. are performed at 
one of these three sites. The clinical indication for all E.E.G.s performed during the 
study period was reviewed and all possible first seizures and new diagnosis of 
epilepsy were included.  
ii) R.A.S.C.. One consultant epileptologist works in the public service in the capture 
region (author D.C). This consultant runs a R.A.S.C. once per week with an aim of 
rapidly reviewing G.P. and emergency department referrals for ‘query seizure’. All 
new referrals to this clinic were reviewed on a weekly basis.  
iii) Survey of hospital consultants. Consultant physicians in neurology and geriatrics 
departments in the seven hospitals outlined above were contacted via postal survey 
every 8-12 weeks and asked to alert us if they were aware of any new case.  
iv) Hospitals outside of the capture region. We acknowledge the possibility that a 
small proportion of patients whose residence is toward the outer edge of the 
capture region may present acutely to a regional hospital outside of the county. 
There are three acute hospitals in the neighboring counties with four consultant 
neurologists working between them. Each neurologist was contacted via a postal 
survey every 8-12 weeks and asked to alert us if they were aware of any new case 
which met our inclusion criteria.  
v) General practice. All G.P.s in the defined region were contacted via postal survey 
every 12 weeks and asked to alert us if s/he was aware of any new case.  
vi) Nursing Home and Residential Care survey. Clinical Nurse Manager of all 
registered nursing homes and residential care services were contacted via postal 
survey every six months and asked to alert us if s/he was aware of any new case. A 
six-month interval was chosen for nursing homes as case turnover is much lower 
than in general practice and we felt that recall would therefore be longer.  
vii) Epilepsy Ireland. Epilepsy Ireland is a non-profit, nationwide patient advocacy 
and advice organisation for people with a diagnosis of epilepsy 
(www.epilepsyireland.ie). In order to rigorously identify any patient who may be 
resident in the defined area but who was diagnosed outside of one of the included 
hospitals, we contacted the local branch of Epilepsy Ireland. They reviewed their 
new patient database to identify patients who were ordinarily resident in the 
defined area but were diagnosed elsewhere. An Epilepsy Ireland staff member then 
consented the patient for inclusion in the study and forwarded their details to the 
study team.  
 
Of note, we deliberately did not choose pharmacy data on A.E.D. prescribing or 
hospital coding databases for case ascertainment because in Ireland these databases 
are not linked to other medical data and typically do not discriminate between new 
cases and established cases of epilepsy.  
 
3.3.3 Identifying under ascertainment 
 
As a method of internal control, to determine if we were missing potential cases, we 
devised a method of assessment of case under ascertainment. We identified that 
patients with a known diagnosis of primary or secondary brain tumors are at 
increased risk of seizures [15]. We prospectively collected the MRNs of patients 
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discussed at the multidisciplinary neuro-oncology meeting of one tertiary referral 
university hospital from January to March 2017. Six months later, at the end of 
September 2017, we searched the medical records of these patients to identify if any 
had presented with a seizure. For any patient who had a seizure, we then crossed 
referenced them to our main database to see if they had already been captured 
through another method of ascertainment. 
 
3.4 Case analysis 
 
3.4.1 Demographic data and clinical data 
 
The paper medical record of each patient identified through the above methods was 
obtained from the medical records department. The first author (E.M.) abstracted 
the demographic details, clinical admission details and results of all relevant 
investigations of each case through medical chart review. For any patient who was 
reviewed and diagnosed by a consultant neurologist, we adhered to the final 
diagnosis of the consultant neurologist. For all patients who were not reviewed by a 
consultant neurologist, the case was analysed by E.M and D.C. and a consensus 
decision was made. Any patient without a clear consensus was further analysed at 
panel review with a second consultant epileptologist (E.C.). D.C. and E.C. are trained 
neurologists who completed epilepsy fellowships and have more than 9 years clinical 
experience running epilepsy services.   
 
3.4.2 Case classification 
 
Following record review, patients were classified as one of the following five 
categories; first provoked seizure, first single unprovoked seizure, new diagnosis of 
epilepsy, seizure mimic or indeterminate event (see Figure 1). Individuals with a first 
single unprovoked seizure were classified as new diagnosis of epilepsy when it was 
estimated that there was a greater than 60% chance of a recurrent epileptic seizure 
in the next 10 years, as per the ILAE operational definition of epilepsy [2]. Otherwise, 
they remained classed as first unprovoked seizure. For definite new cases of 
epilepsy, the seizure and epilepsy type were subclassified as focal, generalized or 
unknown according to the ILAE 2017 classification system [3]. Cases were classified 
as indeterminate, following discussion panel review, if there was insufficient clinical 
information to accurately classify the case.  
 
The 2011 ILAE Epidemiology Commission report on standards for epidemiologic 
studies and surveillance of epilepsy [4] provides a classification system for the level 
of evidence available to support a diagnosis of an epileptic seizure, or new diagnosis 
of epilepsy, based on the level of epidemiologic evidence available. Based on these 
standards, the following classification regarding level of evidence of both single 
epileptic seizures and new diagnosis of epilepsy were applied:  
i) Definite: with primary documentation of (a) epileptic seizures, with evidence that 
these were unprovoked by any acute medical condition or transient brain disorder or 
(b) documentation of diagnosis by someone with appropriate specialised training in 
the recognition of epilepsy. Clear evidence of epileptic seizures was most often 
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based on documented collateral history or documented history by medical staff in 
the case on inpatient events. In the event of a single documented seizure, evidence 
of an approximate 60% risk of recurrence was determined based on the presence or 
absence of risk factors for recurrence such as epileptiform abnormality on E.E.G. or 
significant brain imaging abnormality [16-19]. 
ii) Probable: with other sources of information indicating the likelihood that criterion 
(a) or (b) above is met. For example, cases were defined as probable where there 
was a history strongly suggestive of an epileptic seizure, but a witnessed history was 
not recorded. 
iii) Suspect: where primary or other sources of information suggest a possibility of 
epilepsy but neither (a) or (b) above is met. Possible epileptic seizures were defined 
as an event of which an epileptic seizure was one of a number of plausible 
differential diagnoses, but of which it was not possible to determine which was the 
most likely.  
 
 
3.4.3 Accuracy of case information and classification 
 
In order to ensure the data obtained from the medical records on each case was 
accurate and consistent, an internal audit of the data extraction was performed (by 
E.C.).  Thirty-eight items were recorded from three randomly selected charts. Out of 
these 114 items (3x38), three items were discordant between E.C. and E.M. data 
extraction, resulting in a 97.4% concordance. None of the three discordant items 
altered the clinical diagnosis.  
 
In order to ensure reliability of case classification, ten randomly selected cases were 
reviewed (by E.C).  In the final classification, nine of the ten cases were in 
concordance. However, the internal audit highlighted the subjectivity of the ILAE 
practical diagnosis of epilepsy guidelines.  In discussion, six of the 10 cases did not 
undoubtedly meet this criterion, and while all team neurologists agreed that these 
patients would be commenced on an A.E.D. due to risk of further seizures, whether 
this risk reached the 60% threshold was open to debate.   
  
 
4. Results  
 
The above protocol was applied to our study population from 1st January to 31st 
March 2018 in order to capture all patients who presented to medical services with a 
suspected first seizure or new diagnosis of epilepsy during the calendar year 2017.  
To demonstrate the protocol application, we present the results of the first three 
months of case ascertainment, 1st January 2017 to 31st March 2017.  
 
A flow diagram of the potential cases of first seizure or newly diagnosed epilepsy 
from January 1st 2017 to March 31st 2017 is shown in Figure 2. Four hundred and 
forty two cases were initially identified. Following review of patient charts, 159 
(40%) were excluded as they did not meet the inclusion criteria. The most common 
reason for exclusion was previously diagnosed epilepsy (n=69, 16%) or recurrent 
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provoked seizures (n=25, 6%). Two hundred and eighty-three patients were included 
and were distributed between 6 of the 7 hospitals in Cork city and county. 
 
A pie chart illustrating the overlapping hospital-based sources of case ascertainment 
is shown in Figure 3. Of the 283 included cases, fifty-five percent (n=156) were 
identified by a single source of case ascertainment, 27% (n=76) were identified by 
two sources, 11% (n=31) by three sources and 7% (n=20) were identified by more 
than three sources of ascertainment. No single case was identified by all of the 
methods of case ascertainment. Regarding the contribution of individual sources of 
case ascertainment, almost 54% of cases were identified by reviewing radiology 
databases, see Table 2. The highest number of cases that was ‘unique to source’, 
meaning not identified elsewhere, came from review of E.E.G. databases.  
 
Figure 4 illustrates the first round of postal surveys of G.P.s in the defined area. The 
response rate was 58%. Five G.P.s wrote back to indicate that they were retired and 
were therefore excluded from future surveys. Twenty-four potential cases were 
identified through this postal survey; however 8 were subsequently excluded as they 
did not meet the inclusion criteria. Sixteen cases were included in the study, none of 
which was unique to the G.P. survey in terms of source of case ascertainment. The 
community based patient advocacy group Epilepsy Ireland reviewed their records 
and did not yield any new cases diagnosed outside of a Cork hospital in the first 
three months of cases ascertainment.  
 
Figure 5 illustrates the break-down of identified patients into each of the five 
subclassifications- first provoked seizure, first unprovoked seizure, new diagnosis of 
epilepsy, seizure mimics and indeterminate. Among the 95 cases of new diagnosis of 
epilepsy, 75 (79%) were patients who had a first seizure in 2017, and had an 
estimated greater than 60% chance of further seizures, therefore met the criteria for 
a practical definition of epilepsy [2]. Seventy-one of the new diagnosis of epilepsy 
were considered definite, and of these 71% (n=50) were focal, 18% (n=13) were 
generalized and in 11% (n=8) cases it was unknown whether epilepsy was focal or 
generalized according to the ILAE 2017 subclassification of seizure and epilepsy type. 
Seizure mimics represented the largest group (n=113, 40% of all reviewed case 
records) and the most commonly encountered seizure mimic was syncope (40%, 
n=45). There were 10 (3%) indeterminate cases in the first three months of data 
collection. Extrapolating the first three months of data, the crude incidence for new 
diagnosis of epilepsy in our population was 59 per 100,000 people per year, however 
it is necessary to highlight that this is an estimated rate which is likely to increase as 
it does not allow for ‘late entries’ due to lag in case ascertainment methods. The 
incidence is higher than previous studies outlined in Table 3 and therefore reinforces 
the importance of multiple methods of case ascertainment.  
 
To estimate potential case under-ascertainment, 63 patients were identified by 
screening three months of multidisciplinary neuro-oncology meetings at a tertiary 
referral center. Of these, 5 had a previous diagnosis of epilepsy and 36 were not 
resident in the defined area therefore were not eligible for inclusion in the study. 
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The medical charts of the remaining 22 patients were reviewed and none had a 
documented seizure during follow-up.   
 
 
5. Discussion  
 
We present an epidemiological protocol that adheres to recently published 
international guidelines for investigation of the incidence of epilepsy within a 
population [4,10]. Furthermore, we have incorporated recently updated ILAE 
guidelines for the clinical classification of seizures and epilepsy [11,12] which have 
not yet been used in epidemiological studies but which will be of increasing 
importance in international epilepsy research. Our case ascertainment protocol is 
rigorous and, when data analysis is complete, will be the first to report the incidence 
of epilepsy, first unprovoked seizures and first provoked seizures in Ireland. Finally, 
to our knowledge, this will be the first study to additionally report the incidence and 
characteristics of ‘seizure mimics’ within the same population that seizures and 
epilepsy are under study. Inclusion of the related diagnosis of first seizures, epilepsy 
and seizure mimics in our study protocol gives a sense of the scale of this cohort and 
the significant impact on healthcare services investigating and treating these 
patients. Further details on age-adjusted incidence , seizure and epilepsy etiology, 
and classification will be reported separately when annual incidence data is 
complete.   
 
Many previous epidemiologic studies have focused on a specific cohort within a 
population, for example children or the elderly. Relatively few have included all age-
groups and, within those studies, all available case ascertainment methods range 
from use of a single source  to multiple overlapping sources, see Table 3. With regard 
to case ascertainment in our study, we aimed for full capture of new events by 
combining as many methods of ascertainment as was practicable in our population. 
As shown in Table 3, the majority of other studies do not use such an extensive 
combination of methods. For example, Jallon et al., 1997 [20] used E.E.G. database 
as the sole method of case ascertainment. In our study, E.E.G. databases identified 
only 53% of cases. Furthermore, our interim three-month analysis demonstrates the 
importance of including all possible methods of ascertainment as no single case was 
picked up in every method. In addition, we specifically targeted inpatient teams and 
CNSs with a high likelihood of encountering a patient with a first seizure, for 
example, the neurosurgical and oncology teams, and contacted them on a regular 
basis to maximize case ascertainment. These methods identified 10 ‘unique to 
source’ cases, not identified by other methods in the first three months of case 
ascertainment. To our knowledge, this is the first study to apply such a method. 
 
The seminal work by Hauser and Kurland, 1975 [21] in Rochester Minnesota 
demonstrates the usefulness of accurate medical record databases to perform 
epidemiologic studies. However, such medical record linkage systems are not 
available in many countries, including Ireland, and therefore in order to obtain 
accurate epidemiologic data overlapping methods of case ascertainment are 
required. Data obtained from cohort specific databases were used by Annegers et 
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al., 1999 [22] to describe the incidence of epilepsy in a multiethnic urban population 
(35.5 per 100,000). However, this database contained information only on those 
enrolled in a health maintenance organization served by a particular clinic and was 
therefore findings may not be generalizable to the whole population as the clinic 
served only people in employment and their dependents. Correspondingly, this 
study demonstrated low incidence among those over 65 years of age, in contrast to 
most other studies. Therefore, in populations where accurate, whole population, 
medical record databases are not in existence, multiple over lapping methods of 
ascertainment, in combination with medical chart review, as demonstrated by our 
study, provide detailed information for case identification, classification and 
determination of etiology.   
 
An early study in Italy [25] was unique in its use of social workers and teachers in the 
community to maximize case ascertainment, see Table 3. However, due to ethical 
and practical considerations this would no longer be a viable source of case 
ascertainment. Finally, studies carried out in lower income countries, with less well 
developed health resources, have used door-to-door community surveys to ascertain 
cases, for example [26,27]. However, this method is vulnerable to under-
ascertainment if stigma is associated with epilepsy and seizures in the population. 
Furthermore, accuracy of diagnosis and classification of cases is difficult when this 
method is used in isolation. Therefore, when adequate health resources permit, such 
as in our study, the use of hospital-based databases to identify and classify patients 
based on clinical information is preferable.  
 
Other potential sources of case ascertainment were also considered. Previously 
published studies investigating adult populations have used A.E.D. prescription 
databases as a source of case ascertainment [23, 24]. However, it was not possible to 
use A.E.D. prescribing databases in our case ascertainment for a number of reasons. 
Firstly, drug prescribing data are not linked to other patient records in our 
population, therefore it would not have been possible to cross reference such 
information to our database. Secondly, patients presenting with a first seizure or 
seizure mimic may not routinely be prescribed an A.E.D. and therefore would not be 
captured by such a method. Thirdly, A.E.D.s are often used for indications other than 
epilepsy, such as neuropathic pain, and therefore may overestimate the diagnosis of 
epilepsy. Finally, use of a drug prescription database over the course of a year, 
without linkage to other patient records, would not give an accurate account of 
patients who were newly prescribed the medication. Therefore, in our population, 
such a method would be more appropriately applied to estimating prevalence of 
epilepsy rather than incidence, as was demonstrated by Linehan et al., in 2010 [13].  
 
Very few studies address under-ascertainment. MacDonald et al., 2000 [28] cross-
referenced general practice databases with local hospital patient administration 
system to try to ensure complete ascertainment. However, this method relies on 
accurate and complete case coding. For a number of patients, a seizure may not be 
the primary reason for attending hospital, for example, patients incorrectly initially 
diagnosed as a stroke, or patients who have their first seizure while medically unwell 
for another reason. To our knowledge, our study is the first to design a unique 
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method of following ‘at risk’ patients as a method of assessment of under-
ascertainment. However, for the first three months of data collection, none of these 
at risk patients proceeded to have a seizure. We propose to follow this cohort for a 
longer time-frame in order to determine under-ascertainment and validate this 
unique method. On the other hand, it is reassuring that no community obtained case 
(from general practice or nursing homes) had not been identified already using the 
hospital-based methods, and therefore this serves as somewhat of a surrogate of 
complete ascertainment.  
 
Our study highlighted the subjectivity involved in determining whether, following a 
single seizure, a person is at greater than 60% risk of further seizures, as found by 
our panel discussion. The Multicenter Trial for Early Epilepsy and Single Seizures 
(MESS) [29] provides some guidance on assessing this risk. However, the MESS study 
did not include neuroimaging as part of its risk stratification tool and there remains a 
lack of up-to-date, real world clinical data in certain populations, for example, older 
adults with established small vessel ischaemic disease with juxtacortical signal 
changes on brain imaging. In clinical practice, many patients commence an A.E.D. 
because they are considered at some risk of recurrent events, even though the exact 
risk is unquantifiable. The 2014 ILAE practical definition of epilepsy does not require 
the clinician to quantify the risk precisely. Therefore, we have included patients 
within the cohort of new diagnosis of epilepsy who were determined to be at an 
approximate 60% risk of recurrent seizures based on the evidence available to date. 
Further study of individuals at the margin of this risk threshold is required.  
 
We are aware of potential gaps in case ascertainment, for example people who did 
not seek medical help after a seizure, people who do not recognize that they have 
had a seizure(s) and vulnerable patients unable to access medical care including 
homeless people, non-verbal individuals and people living alone. In addition, 
epilepsy and mimics largely are based on clinical history. In a small number of cases 
the treating physician may not recognize seizure as a potential diagnosis.  However, 
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8. Figure Legends 
 
Table 1. Examples of provoked seizures in association with disruption of the 
structural or functional integrity of the brain, adapted from the ILAE Standards for 
Epidemiologic Studies [4] 
 
Cause [14] Period of occurence Notes/exceptions 
Cerebrovascular disease 
[26-28] 
First 7 days  
Traumatic brain injury 
[28,29] 
First 7 days Included intracranial 
surgery.  
Longer intervals are 
acceptable for subdural 
haematoma in the absence 
of known trauma or at first 
identification of 
haematoma. Subsequent 
seizures are unprovoked.  
CNS infection [28] First 7 days Included seizures occuring 
after 7 days in patients 
with persistent clinical 
and/or laboratory signs of 
infection. 
Cerebral tuberculoma [14] During treatment Seizures occuring after 
successful treatment are 
unprovoked 
Brain abscess [14] During treatment Seizures occuring after 
successful treatment are 
unprovoked 
HIV infection [14] Acute infection or severe 
metabolic disturbance 
Seizures occuring in the 
absence of oppotunistic 
CNS infection or severe 




In the presence of acute 
haemorrhage 
All other seizures are 
unprovoked 
Multiple sclerosis [14] First presenting symptom 
within 7 days of relapse 
 







Table 2. Cases identified at each source expressed to the nearest percentage. 
R.A.S.C.= Rapid access seizure clinic; C.N.S.= Clinical nurse specialist 
 
All included potential first seizure or new diagnosis epilepsy patients (n=283) 
Source Number of cases (%) Unique to source (%) 
Radiology 153 (54%) 45 (16%) 
E.E.G. 151 (53%) 60 (21%) 
Emergency department  70 (25%) 27 (9%) 
Hospital Doctors 53 (19%) 9 (3%) 
R.A.S.C. 45 (16%) 14 (5%) 
Community survey 16 (6%) 0 (0%) 
C.N.S. 11 (4%) 1  (<1%) 





Table 3. Comparison of case ascertainment methods in previous studies investigating the incidence of epilepsy and/or first seizures 
within a population. Studies included all age groups within the population studied.  E.E.G.= electroencephalogram. R.A.S.C= Rapid Access 





al., 2005 [34] 
MacDonald et 
al., 2000 [28] 
Jallon et al., 
1999 [35] 
Jallon et al., 
1997 [20] 





al., 1983 [25] 
Hauser and 
Kurland, 































Case ascertainment           
Radiology database X X         
E.E.G. database X X   X X X X  X 
Emergency Department X X  X       
Neurologists/Paediatricians X X  X  X  X   
Other hospital specialists X X         
R.A.S.C. X  X        
Clinical Nurse Specialist X          
G.P. survey X X X X   X X   
Residential care survey X X         
Patient Advocacy Group X          
Hospital medical record 
data 
  X     X X X 
School teachers and social 
workers 
       X   
Incidence of first 
unprovoked seizures (per 
100,000) 
 56.8 11 64.1 45.6 71.3 (all 
seizures) 
  23.6 (all 
seizures) 
 
Incidence of first provoked 
seizures (per 100,000) 
   16.4 25.2      
Incidence of epilepsy (per 
100,000) 





Figure 1. Overview of case ascertainment, case analysis and case classification 
protocol. E.E.G.= electroencephalogram. R.A.S.C= Rapid Access Seizure Clinic. 






Figure 2. Flow diagram of identification of potential cases of first seizure and newly 







Figure 3. Pie chart demonstrating overlapping sources of hospital based case 
ascertainment during study period 1st January to 31st March 2017 (n=283). The chart 
shows the proportion of included cases identified uniquely by each of the six hospital 
based methods as well as the proportion of cases identified by 2, 3 or more than 3 
individual sources. C.N.S.= Clinical Nurse Specialist, E.D.= Emergency Department, 






Figure 4. Flow diagram illustrating case ascertainment by postal survey of all G.P.s in 
the capture region during study period 1st January to 31st March 2017. A total of 16 
cases were included from this method of ascertainment, all of whom had been 





Figure 5. Number of cases in each subgroup following panel review of case 
information. Of the 95 cases of new diagnosis of epilepsy, 75 also presented with 
their first seizure and were determined to be at greater than 60% risk of recurrent 
seizures. IQR= interquartile range, m=months, w=weeks, y=years.  
 
 
 
